看這個

來源: fuz 於 2019-06-12 07:50:54 [] [博客] [舊帖] [給我悄悄話] 閱讀數 : (1538 bytes)
本帖於 2019-06-12 08:04:48 時間, 由普通用戶 fuz 編輯

臨試 

https://clinicaltrials.gov/ct2/show/NCT03715114

https://ichgcp.net/clinical-trials-registry/NCT02293915

 

 

另幾篇報道

https://www.biospace.com/article/releases/novel-drug-treatment-shows-improved-cognition-in-a-phase-3-clinical-trial-in-persons-with-mild-to-moderate-alzheimer-s-disease-in-china/ 

https://www.thepharmaletter.com/article/alzheimer-s-treatment-from-china-meets-phase-iii-goal

 

那個藥

”GV-971 is a novel, marine-derived oligosaccharide, which has multi targeting mechanisms including inhibition of amyloid-β fibril formation, neuroinflammation, and recondition of dysbiosis of gut microbiota",

 

長期效果及副作用有待進一步評估

 

 

所有跟帖： 

• 謝謝夫子的信息 -越王- ♂ 給 越王 發送悄悄話 越王 的博客首頁 (0 bytes) () 06/12/2019 postreply 08:07:07

請您先登陸，再發跟帖！